New book by Larry Connors Click here Improve your trading - See how
Genzyme (GENZ) Momentum Alert: 3.6% Move in 17 Days -
Genzyme Provides Update on Allston Plant -
Drug maker begins cleanup to kill virus -
Virus pushes drug maker to halt production -
Genzyme Reports Progress Related to Allston Plant -
Genzyme Down 4.5% Since SmarTrend's Sell Recommendation -
Genzyme Temporarily Stops Production at Allston Plant -
Genzyme halts drug production amid scare -
Schaeffer's Option Blog: Put Trading Soars on Genzyme Corporation (GENZ) -
Genzyme Traded At Lowest Level In 1 1/2 Months -
Genzyme Falls In Pre-Market After Interrupting Production At Plant -
Genzyme Closed Monday at Five-Week Low -
Genzyme's Chronic Kidney Disease Treatment gets European Commission Approval - Update -
Genzyme Receives European Approval of Renvela for Patients with Chronic Kidney Disease -
Genzyme Completes Transaction with Bayer HealthCare -
Genzyme Receives Positive Opinion for European Approval of Mozobil -
Genzyme makes final submission to FDA on Lumizyme -
Genzyme Submits All Information Requested by FDA for Lumizyme -
Genzyme Presents New Clinical Data and Key Business Updates -
GENZ touches 50-day moving average at 58.40 -
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
